BOLOGNESI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 7.417
NA - Nord America 6.573
EU - Europa 4.753
AF - Africa 470
SA - Sud America 376
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 19.602
Nazione #
US - Stati Uniti d'America 6.458
VN - Vietnam 2.064
SG - Singapore 2.027
CN - Cina 1.740
IT - Italia 1.188
GB - Regno Unito 933
HK - Hong Kong 639
DE - Germania 534
SE - Svezia 450
FR - Francia 286
UA - Ucraina 265
IN - India 256
BR - Brasile 250
RU - Federazione Russa 231
CI - Costa d'Avorio 193
NL - Olanda 186
IE - Irlanda 169
FI - Finlandia 141
ZA - Sudafrica 140
KR - Corea 136
JP - Giappone 121
CA - Canada 77
BG - Bulgaria 66
EE - Estonia 64
PH - Filippine 53
ID - Indonesia 49
AR - Argentina 48
TH - Thailandia 47
JO - Giordania 45
BE - Belgio 43
ES - Italia 38
TG - Togo 34
BD - Bangladesh 32
IQ - Iraq 32
TR - Turchia 28
TW - Taiwan 28
AT - Austria 27
PK - Pakistan 27
SC - Seychelles 27
CH - Svizzera 24
PL - Polonia 24
IR - Iran 22
GR - Grecia 19
MX - Messico 19
EC - Ecuador 18
MY - Malesia 17
CL - Cile 16
NG - Nigeria 16
CO - Colombia 13
SA - Arabia Saudita 13
DZ - Algeria 12
PY - Paraguay 12
LY - Libia 11
UZ - Uzbekistan 11
RO - Romania 9
AU - Australia 8
EG - Egitto 8
LT - Lituania 8
ET - Etiopia 7
PT - Portogallo 7
VE - Venezuela 7
DK - Danimarca 6
PE - Perù 6
CZ - Repubblica Ceca 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
RS - Serbia 5
HR - Croazia 4
LB - Libano 4
MA - Marocco 4
NO - Norvegia 4
TN - Tunisia 4
UY - Uruguay 4
BW - Botswana 3
CR - Costa Rica 3
HN - Honduras 3
LK - Sri Lanka 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GU - Guam 2
KE - Kenya 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BB - Barbados 1
GA - Gabon 1
GH - Ghana 1
GP - Guadalupe 1
IL - Israele 1
IS - Islanda 1
Totale 19.585
Città #
Singapore 1.398
Southend 748
Ashburn 626
Hong Kong 606
Santa Clara 552
Ho Chi Minh City 529
Fairfield 510
Chandler 508
Hanoi 451
Bologna 395
San Jose 308
Hefei 276
Woodbridge 253
Beijing 251
Houston 245
Wilmington 234
Ann Arbor 214
Seattle 209
Princeton 203
Abidjan 193
Jacksonville 192
Cambridge 185
Boardman 182
Dublin 169
Dong Ket 158
Council Bluffs 128
Seoul 110
Helsinki 109
Los Angeles 108
Lauterbourg 100
Tokyo 100
Nanjing 91
Westminster 81
Padova 79
Berlin 77
Milan 77
Turin 75
Sofia 65
Johannesburg 64
Buffalo 61
Haiphong 61
Da Nang 59
Jinan 59
Saint Petersburg 54
New York 49
Amman 45
Frankfurt am Main 45
Brussels 43
Falkenstein 43
Shanghai 42
Guangzhou 41
Redondo Beach 41
Shenyang 41
Mülheim 39
Medford 37
Hebei 36
San Diego 35
Lomé 34
Dallas 33
Biên Hòa 32
Nanchang 32
Redmond 32
Changsha 31
Lappeenranta 31
London 29
São Paulo 28
Tianjin 27
Zhengzhou 27
Thái Nguyên 26
Toronto 26
Bangkok 25
Bengaluru 25
Orem 25
Phoenix 24
Rome 24
Jakarta 23
Des Moines 22
Hangzhou 22
Can Tho 21
Redwood City 21
Ha Long 20
Forlì 19
Mahé 19
Bern 18
Quận Bình Thạnh 18
Taiyuan 18
Chicago 17
Hải Dương 17
Warsaw 17
Abeokuta 16
Kunming 16
Taizhou 16
Wuhan 16
Dearborn 15
Hyderabad 15
Kuala Lumpur 15
Naples 15
Nuremberg 15
Amsterdam 14
Montreal 14
Totale 12.640
Nome #
Journal of Biological Regulators and Homeostatic Agents 305
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma 276
Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1 242
Membrane lipidome reorganization correlates with the fate of neuroblastoma cells supplemented with fatty acids. 232
Survival and death of intestinal cells infected by Chlamydia trachomatis 221
The 1.4.ANG. structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins. 220
Distribution of RIP activity in tissue extracts from Fragaria x ananassa (strawberry) and its correlation with environmental stress 220
Ricin: An ancient story for a timeless plant toxin 219
Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae) 215
In vitro and in vivo toxicity of type 2 ribosome-inactivating proteins lanceolin and stenodactylin on glial and neuronal cells. 215
Ribosome-inactivating proteins in edible plants and purification and characterization of a new ribosome-inactivating protein from Cucurbita moschata. 214
High in vitro anti-tumor efficacy of dimeric rituximab/saporin-S6 immunotoxin 212
Binding and intracellular routing of the plant-toxic lectins, lanceolin and stenodactylin 211
Detection of ricin and other ribosome-inactivating proteins by an immuno-polymerase chain reaction assay 209
RIP activity in basic protein fractions of tissue extracts from Fragaria x ananassa 208
Structure/function studies on two type 1 ribosome inactivating proteins: Bouganin and lychnin. 205
Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering? 204
(ClO4)2: Metallodrug Nanocontainer Delivery and Membrane Lipidomics of a Neuroblastoma Cell Line Coupled with a Liposome Biomimetic Model Focusing on Fatty Acid Reactivity 203
Rituximab and other new anti-CD20 mAbs for non-Hodgkin’s lymphoma treatment. 200
Two Saporin-Containing Immunotoxins Specific for CD20 and CD22 Show Different Behavior in Killing Lymphoma Cells 196
Internalization and recycling of ALCAM/CD166 detected by a fully human single-chain recombinant antibody. 192
Potential therapeutic application of the plant toxin saporin-S6. 189
Ribosome-inactivating proteins from plants: A historical overview 189
Saporin-S6: a useful tool in cancer therapy. 187
Plants Producing Ribosome-Inactivating Proteins in Traditional Medicine 186
ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells. 183
Structure/funcion studies on type 1 ribosome inactivating proteins. 182
Endocytosis and intracellular localisation of type 1 ribosome-inactivating protein saporin-s6 182
Hyperuricaemia, xanthine oxidoreductase and ribosome-inactivating proteins from plants: The contributions of fiorenzo stirpe to frontline research 182
The 1.4 Å Structure of Dianthin 30 Indicates a Role of Surface Potential at the Active Site of Type 1 Ribosome Inactivating Proteins 181
Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase 181
Sequence determination of lychnin, a type 1 ribosome-inactivating protein from Lychnis chalcedonica seeds. 180
Crystallization and preliminary X-ray diffraction data analysis of stenodactylin, a highly toxic type 2 ribosome-inactivating protein from Adenia stenodactyla. 180
CD38 as a target of IB4 mAb carrying saporin-S6: Design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia 180
The role of xanthine oxidoreductase and uric acid in metabolic syndrome 180
The fundamental contribution of prof. Stirpe (and his research group) to the broadening of the scientific perspective on xanthine oxidoreductase 179
Kirkiin: A New Toxic Type 2 Ribosome-Inactivating Protein from the Caudex of Adenia kirkii 179
Immunotoxins and Other Conjugates Containing Saporin-S6 for Cancer Therapy 177
Plant Toxins as Potential Alternatives to Botulinum Toxin for Eye-Movement Disorder Therapy 176
New Insights on Saporin Resistance to Chemical Derivatization with Heterobifunctional Reagents 176
Immunotoxins and other conjugates: pre-clinical studies. 176
Early Response to the Plant Toxin Stenodactylin in Acute Myeloid Leukemia Cells Involves Inflammatory and Apoptotic Signaling 174
Heterophyllin: A New Adenia Toxic Lectin with Peculiar Biological Properties 172
A new potent and selective anti-lymphocytes-immunotoxin for the treatment of GVHD and lymphocyte-derived neoplasms 172
Anti-tumor activity of Epratuzumab/saporin-S6. 170
Structural studies on RIPs elucidates the differences in their action on polynucleotides. 168
CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction 168
Xanthine oxidoreductase: One enzyme for multiple physiological tasks 168
Rilevazione di ricina e di altre ribosome-inactivating protein mediante un saggio di immuno-polymerase chain reaction. 167
Xanthine Oxidoreductase in Drug Metabolism: Beyond A Role as a Detoxifying Enzyme 166
Antibody conjugates for sarcoma therapy: How far along are we? 166
Xanthine oxidoreductase in cancer: more than a differentiation marker 164
Epratuzumab/Saporin-S6: an anti-CD22 immunotoxin for selective depletion of B-cells neoplasms 164
Bouganin, an attractive weapon for immunotoxins 164
Due nuove tossine per la chemoablazione sperimentale nello strabismo e nei disordini del movimento (blefarospasmo). 161
Programmed death induced by saporin as compared to ricin in lymphoma cells. 159
Expression of CTLA-4 in non-human primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies. 159
Structure and Biological Properties of Ribosome-Inactivating Proteins and Lectins from Elder (Sambucus nigra L.) Leaves 158
Insights into penicillin-induced Chlamydia trachomatis persistence 158
Cell interaction of the type 1 RIP Saporin 157
Protein synthesis inhibition activity by strawberry tissue protein extracts during plant life cycle and under biotic and abiotic stresses 156
Hexadecenoic Fatty Acid Positional Isomers and De Novo PUFA Synthesis in Colon Cancer Cells 155
Targeting CTLA-4 by its recombinant ligands CD80/CD86: Perspectives towards the development of a novel anti-tumor therapeutic approach. 151
Neurotossicità in vitro e in vivo delle ribosome-inactivating proteins lanceolina e stenodettilina. 150
Two different in vitro tests confirm the blocking activity of d-galactose lectins on the adhesion of Escherichia coli F4 to pig brush border receptors 149
Epratuzumab/saporin-S6: a new anti-CD22 immunotoxin with a potent antitumour activity. 149
The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20 expressing cells and produces a synergistic toxic effect with Fludarabine 148
Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives 148
Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme. 146
Research of new ribosome-inactivating proteins from adenina genus (Passifloraceae); characterization of highly toxic type 2 RIPs from Adenia lanceolata and Adenia stenodactyla. 146
Increased serum level of xanthine oxidoreductase in liver transplanted patients. 146
Morte cellulare programmataindotta dalle RIP ricina e saporina in cellule linfomatose. 145
mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment. 144
Primi studi sull'attività Rip in fragola. 143
Xanthine Oxidoreductase In Atherosclerosis Pathogenesis: Not Only Oxidative Stress. 141
Sequence, structure, and binding site analysis of kirkiin in comparison with ricin and other type 2 rips 139
Epratuzumab/saporina-S6: una immunotossina anti-CD22 per la deplezione delle cellule B linfomatose 138
Toxin and Immunotoxin Based Therapeutic Approaches 137
B-b10 (Anti-CD25)-saporin immunotoxin—a possible tool in graft-versus-host disease treatment1 137
Ribosome‐Inactivating Proteins (RNA N‐glycosidases) from the Seeds of Saponaria ocymoides and Vaccaria pyramidata 137
Saporin induces multiple death pathways in lymphoma cells with different intensity, timing as compared to ricin. 136
Intracellular fate of saporin-S6, a putative drug for anti-cancer therapy 134
Toxins 134
EVALUATION OF PLANT RIBOSOME-INACTIVATING PROTEIN TOXICITY ON INTESTINAL CELLS 131
Distribuzione dell’attività lectinica e tossica in piante appartenenti al genere Adenia (Passifloraceae) 130
Xanthine oxidoreductase: A leading actor in cardiovascular disease drama 123
The ATG-saporin-S6 immunotoxin causes a complete depletion of activated T cells. 122
Chronic kidney disease: Which role for xanthine oxidoreductase activity and products? 122
Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: Effect on DNA, RNA and poly(A) 120
hLL2/saporin: un’immunotossina anti-CD22 con potente attività antitumorale. 119
Occupational sensitization to ribosome-inactivating proteins in researchers 119
Gender Influence on XOR Activities and Related Pathologies: A Narrative Review 118
Xanthine Oxidoreductase: A Double-Edged Sword in Neurological Diseases 116
L’immunotossina ATG/ saporina-S6 per l’eliminazione specifica di linfociti T attivati. 115
Primary Sequence and 3D Structure Prediction of the Plant Toxin Stenodactylin 114
CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells 114
Comparative Efficacy of Ribosome-Inactivating Protein-Containing Immunotoxins in 2D and 3D Models of Sarcoma 112
Pro-aging effects of xanthine oxidoreductase products 112
Ribosome-inactivating proteins and other lectins from Adenia (Passifloraceae) 111
Type 1 ribosome-inactivating proteins from Phytolacca dioica L. leaves: differential season and age expression, and cellular localization 109
Totale 16.695
Categoria #
all - tutte 52.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.071


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021513 0 0 0 0 0 0 0 0 0 78 89 346
2021/20221.750 112 69 107 114 131 109 27 132 87 91 424 347
2022/20232.102 253 224 103 243 150 167 63 97 445 73 202 82
2023/2024839 32 109 62 63 54 117 49 117 43 85 62 46
2024/20253.562 163 387 337 199 740 191 171 149 75 250 114 786
2025/20267.034 761 965 600 536 855 390 709 243 1.374 601 0 0
Totale 19.948